GSK Annual Accounts Payable
$4.74 B
+$56.45 M+1.21%
31 December 2023
Summary:
As of January 22, 2025, GSK annual accounts payable is $4.74 billion, with the most recent change of +$56.45 million (+1.21%) on December 31, 2023. During the last 3 years, it has fallen by -$1.20 billion (-20.26%). GSK annual accounts payable is now -56.76% below its all-time high of $10.95 billion, reached on December 31, 2009.GSK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Quarterly Accounts Payable
$19.24 B
+$1.22 B+6.77%
30 September 2024
Summary:
As of January 22, 2025, GSK quarterly accounts payable is $19.24 billion, with the most recent change of +$1.22 billion (+6.77%) on September 30, 2024. Over the past year, it has increased by +$14.50 billion (+306.26%). GSK quarterly accounts payable is now -34.91% below its all-time high of $29.55 billion, reached on March 31, 2018.GSK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.2% | +306.3% |
| 3 y3 years | -20.3% | -16.7% |
| 5 y5 years | +2.4% | -16.7% |
GSK Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.6% | +1.2% | -16.7% | +311.2% |
| 5 y | 5-year | -22.6% | +1.2% | -16.7% | +311.2% |
| alltime | all time | -56.8% | +5327.7% | -34.9% | >+9999.0% |
GSK Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.24 B(+6.8%) |
| June 2024 | - | $18.02 B(-2.4%) |
| Mar 2024 | - | $18.46 B(+289.8%) |
| Dec 2023 | $4.74 B(+1.2%) | $4.74 B(-75.1%) |
| Sept 2023 | - | $19.01 B(+8.0%) |
| June 2023 | - | $17.60 B(-0.4%) |
| Mar 2023 | - | $17.67 B(+277.7%) |
| Dec 2022 | $4.68 B(-23.6%) | $4.68 B(-74.0%) |
| Sept 2022 | - | $18.00 B(+0.2%) |
| June 2022 | - | $17.96 B(-22.2%) |
| Mar 2022 | - | $23.09 B(+277.2%) |
| Dec 2021 | $6.12 B(+3.1%) | $6.12 B(-70.1%) |
| Sept 2021 | - | $20.45 B(+3.6%) |
| June 2021 | - | $19.75 B(-1.7%) |
| Mar 2021 | - | $20.08 B(+238.2%) |
| Dec 2020 | $5.94 B(+9.3%) | $5.94 B(-69.5%) |
| Sept 2020 | - | $19.48 B(+2.4%) |
| June 2020 | - | $19.02 B(+0.4%) |
| Mar 2020 | - | $18.94 B(+248.6%) |
| Dec 2019 | $5.43 B(+17.5%) | $5.43 B(-70.0%) |
| Sept 2019 | - | $18.11 B(+6.8%) |
| June 2019 | - | $16.96 B(-3.1%) |
| Mar 2019 | - | $17.51 B(+278.6%) |
| Dec 2018 | $4.63 B(-3.0%) | $4.63 B(-72.9%) |
| Sept 2018 | - | $17.06 B(+4.0%) |
| June 2018 | - | $16.40 B(-44.5%) |
| Mar 2018 | - | $29.55 B(+519.9%) |
| Dec 2017 | $4.77 B(+7.9%) | $4.77 B(-82.1%) |
| Sept 2017 | - | $26.64 B(+4.6%) |
| June 2017 | - | $25.47 B(+69.7%) |
| Mar 2017 | - | $15.01 B(+239.8%) |
| Dec 2016 | $4.42 B(-4.4%) | $4.42 B(-70.9%) |
| Sept 2016 | - | $15.18 B(+3.7%) |
| June 2016 | - | $14.65 B(-1.6%) |
| Mar 2016 | - | $14.89 B(+222.2%) |
| Dec 2015 | $4.62 B(+6.4%) | $4.62 B(-64.2%) |
| Sept 2015 | - | $12.90 B(+0.6%) |
| June 2015 | - | $12.82 B(+0.8%) |
| Mar 2015 | - | $12.72 B(+193.0%) |
| Dec 2014 | $4.34 B(-3.9%) | $4.34 B(-64.5%) |
| Sept 2014 | - | $12.25 B(+3.5%) |
| June 2014 | - | $11.84 B(-2.6%) |
| Mar 2014 | - | $12.15 B(+169.0%) |
| Dec 2013 | $4.52 B(+4.8%) | $4.52 B(-64.2%) |
| Sept 2013 | - | $12.60 B(+5.4%) |
| June 2013 | - | $11.95 B(+2.0%) |
| Mar 2013 | - | $11.72 B(+172.1%) |
| Dec 2012 | $4.31 B(+8.9%) | $4.31 B(-65.4%) |
| Sept 2012 | - | $12.47 B(+12.2%) |
| June 2012 | - | $11.11 B(-1.3%) |
| Mar 2012 | - | $11.26 B(+184.6%) |
| Dec 2011 | $3.96 B(+19.7%) | $3.96 B(-64.6%) |
| Sept 2011 | - | $11.19 B(-4.2%) |
| June 2011 | - | $11.68 B(+0.3%) |
| Mar 2011 | - | $11.64 B(+252.4%) |
| Dec 2010 | $3.30 B | $3.30 B(-69.3%) |
| Sept 2010 | - | $10.75 B(+9.5%) |
| June 2010 | - | $9.81 B(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $10.32 B(-5.8%) |
| Dec 2009 | $10.95 B(+23.1%) | $10.95 B(+12.5%) |
| Sept 2009 | - | $9.73 B(+14.6%) |
| June 2009 | - | $8.50 B(+3.0%) |
| Mar 2009 | - | $8.25 B(-7.3%) |
| Dec 2008 | $8.90 B(-7.9%) | $8.90 B(-2.9%) |
| Sept 2008 | - | $9.16 B(-13.4%) |
| June 2008 | - | $10.59 B(+0.1%) |
| Mar 2008 | - | $10.57 B(+9.4%) |
| Dec 2007 | $9.66 B(+470.7%) | $9.66 B(-8.1%) |
| Sept 2007 | - | $10.51 B(+19.7%) |
| June 2007 | - | $8.78 B(-1.6%) |
| Mar 2007 | - | $8.92 B(+426.9%) |
| Dec 2006 | $1.69 B(+20.2%) | $1.69 B(-80.4%) |
| Sept 2006 | - | $8.63 B(+4.0%) |
| June 2006 | - | $8.30 B(-3.1%) |
| Mar 2006 | - | $8.57 B(+508.3%) |
| Dec 2005 | $1.41 B(-82.8%) | $1.41 B(-82.6%) |
| Sept 2005 | - | $8.08 B(+5.6%) |
| June 2005 | - | $7.65 B(-2.6%) |
| Mar 2005 | - | $7.85 B(-4.1%) |
| Dec 2004 | $8.19 B(+568.4%) | $8.19 B(+8.2%) |
| Sept 2004 | - | $7.56 B(+6.1%) |
| June 2004 | - | $7.13 B(-47.1%) |
| Mar 2004 | - | $13.47 B(+999.6%) |
| Dec 2003 | $1.22 B(+6.2%) | $1.22 B(-89.2%) |
| Sept 2003 | - | $11.29 B(+2.7%) |
| June 2003 | - | $10.99 B(-2.5%) |
| Mar 2003 | - | $11.28 B(+878.2%) |
| Dec 2002 | $1.15 B(+4.5%) | $1.15 B(-89.8%) |
| Sept 2002 | - | $11.29 B(+0.2%) |
| June 2002 | - | $11.27 B(+6.1%) |
| Mar 2002 | - | $10.62 B(+862.6%) |
| Dec 2001 | $1.10 B(-8.9%) | $1.10 B(-89.5%) |
| Sept 2001 | - | $10.54 B(+9.8%) |
| June 2001 | - | $9.60 B(-7.3%) |
| Mar 2001 | - | $10.36 B(+755.9%) |
| Dec 2000 | $1.21 B(+104.1%) | $1.21 B(-85.5%) |
| Sept 2000 | - | $8.35 B(-1.2%) |
| June 2000 | - | $8.45 B(-0.3%) |
| Mar 2000 | - | $8.48 B(+1329.7%) |
| Dec 1999 | $593.03 M(+22.4%) | $593.03 M(+25.9%) |
| June 1999 | - | $470.92 M(-2.8%) |
| Dec 1998 | $484.59 M(-2.1%) | $484.59 M(-74.8%) |
| June 1998 | - | $1.93 B(+288.8%) |
| Dec 1997 | $495.17 M(+7.9%) | $495.17 M(+7.9%) |
| Dec 1996 | $458.86 M(+1.0%) | $458.86 M(-87.2%) |
| Dec 1995 | $454.50 M(-87.3%) | - |
| June 1995 | - | $3.59 B(+1138.5%) |
| June 1995 | $3.59 B(+1138.5%) | - |
| June 1994 | $289.61 M(+7.8%) | $289.61 M(+7.8%) |
| June 1993 | $268.55 M(-12.8%) | $268.55 M(-12.8%) |
| June 1992 | $307.80 M(+30.0%) | $307.80 M(+30.0%) |
| June 1991 | $236.84 M(+1.4%) | $236.84 M(+1.4%) |
| June 1990 | $233.56 M(+33.4%) | $233.56 M(+33.4%) |
| June 1989 | $175.13 M(+7.9%) | $175.13 M(+7.9%) |
| June 1988 | $162.34 M(+32.7%) | $162.34 M(+32.7%) |
| June 1987 | $122.35 M(+40.3%) | $122.35 M(+40.3%) |
| June 1986 | $87.24 M | $87.24 M |
FAQ
- What is GSK annual accounts payable?
- What is the all time high annual accounts payable for GSK?
- What is GSK annual accounts payable year-on-year change?
- What is GSK quarterly accounts payable?
- What is the all time high quarterly accounts payable for GSK?
- What is GSK quarterly accounts payable year-on-year change?
What is GSK annual accounts payable?
The current annual accounts payable of GSK is $4.74 B
What is the all time high annual accounts payable for GSK?
GSK all-time high annual accounts payable is $10.95 B
What is GSK annual accounts payable year-on-year change?
Over the past year, GSK annual accounts payable has changed by +$56.45 M (+1.21%)
What is GSK quarterly accounts payable?
The current quarterly accounts payable of GSK is $19.24 B
What is the all time high quarterly accounts payable for GSK?
GSK all-time high quarterly accounts payable is $29.55 B
What is GSK quarterly accounts payable year-on-year change?
Over the past year, GSK quarterly accounts payable has changed by +$14.50 B (+306.26%)